API introduction in a multiproduct facility

With the business opportunities arising from the possibility of including a new product in a pharmaceutical plant, quick and clear responses are required on whether the product may or may not be manufactured.

At Azierta, we develop a customised process for each client to define whether the product can be manufactured or whether its manufacture requires the previous implementation of any technical of administrative measures.

• We ensure regulatory compliance in line with the most up-to-date current regulations.
  
• We maximise personnel protection in the plant in line with the API risk.
  
• We have toxicologists specialised in toxicological evaluation to guarantee the viability of the manufacture of each API.

Multidisciplinary team of expert toxicologists accredited by AETOX, EUROTOX and ERT.